Raj Denhoy analyst JEFFERIES

Currently out of the existing stock ratings of Raj Denhoy, 16 are a HOLD (9.2%), 158 are a BUY (90.8%).

Raj Denhoy

Work Performance Price Targets & Ratings Chart

Analyst Raj Denhoy, currently employed at JEFFERIES, carries an average stock price target met ratio of 75.07% that have a potential upside of 26.53% achieved within 420 days.

Raj Denhoy’s has documented 379 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on STAA, STAAR Surgical Company at 09-Apr-2024.

Wall Street Analyst Raj Denhoy

Analyst best performing recommendations are on IART (INTEGRA LIFESCIENCES HOLDINGS).
The best stock recommendation documented was for ESTA (ESTABLISHMENT LABS HOLDINGS) at 1/8/2021. The price target of $50 was fulfilled within 7 days with a profit of $12.09 (31.89%) receiving and performance score of 45.56.

Average potential price target upside

ABMD ABIOMED BSX Boston Scientific Corp DXCM DexCom ESTA Establishment Labs Holdings EW Edwards Lifesciences Corp HOLX Hologic IART Integra LifeSciences Holdings LIVN LivaNova PLC LNTH Lantheus Holdings MDT Medtronic PLC MDWD Mediwound Ltd NUVA NuVasive PODD Insulet TFX Teleflex WMGI Wright Medical Group N.V ZBH Zimmer Biomet Holdings ABT Abbott Laboratories SYK Stryker AXGN Axogen RMD ResMed COO The Cooper Companies Common Stock HAE Haemonetics ATEC Alphatec Holdings STAA STAAR Surgical Company PROF Profound Medical Corp ALGN Align Technology RWLK Rewalk Robotics Ltd TELA Tela Bio ALR Alerislife KMDA Kamada

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell Since 15-Jul-2022

$380

$-1.02 (-0.27%)

$235

3 years 11 months 3 days ago
(02-Nov-2022)

1/2 (50%)

$6.49 (1.74%)

36

Buy Since 18-Jun-2021

$388

$6.98 (1.83%)

$355

3 years 11 months 3 days ago
(02-Nov-2022)

2/5 (40%)

$14.49 (3.88%)

88

Buy Since 22-Feb-2018

$380

$-1.02 (-0.27%)

$350

3 years 11 months 4 days ago
(01-Nov-2022)

24/41 (58.54%)

$2.18 (0.58%)

138

Buy Since 30-Jun-2021

$300

3 years 11 months 22 days ago
(13-Oct-2022)

1/3 (33.33%)

$57.23 (23.57%)

20

$330

$-47.78 (-12.65%)

4 years 5 months 29 days ago
(06-Apr-2022)

1/1 (100%)

$16.24 (5.18%)

209

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Raj Denhoy?

On 2005
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?